Published evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015

Autor:	Grössmann, N, Robausch, M, Rothschedl, E, Wild, C, Simon, J
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	ddc: 610 610 Medical sciences Medicine humanities
Zdroj:	Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20200213-20200215; Basel, Schweiz; DOC20ebmS2-V1-01 /20200212/
DOI:	10.3205/20ebm011
Popis:	Background/research question: Health-related quality of life (HRQoL) is one of the most important patient-relevant study endpoints for the direct measurement of the benefit of cancer drugs. Therefore, our aim was to detect cancer drugs with no published information on HRQoL at the time of European[for full text, please go to the a.m. URL] Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee05e702bc6b5c14c9ce54a556b42aa Zobrazit plný text záznamu